Vector Science and Therapeutics Corp (PAIN)
Market Closed
10 Aug, 20:00
TSX-V TSX-V Primary CA$
1. 59
-0.01
-0.625%
CA$
12.92M Market Cap
- P/E Ratio
- Div Yield
23,624 Volume
0 Eps
CA$ 1.6
Previous Close Want to track PAIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PAIN closed today lower at CA$1.59, a decrease of -0.625% from yesterday's close, completing a monthly decrease of -35.102% or -CA$0.86. Over the past 12 months, PAIN stock gained 231.25%.
PAIN is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
PAIN Chart
Vector Science and Therapeutics Corp (PAIN) FAQ
What is the stock price today?
The current price is CA$1.59.
On which exchange is it traded?
Vector Science and Therapeutics Corp is listed on TSX-V.
What is its stock symbol?
The ticker symbol is PAIN.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 12.92M.
Has Vector Science and Therapeutics Corp ever had a stock split?
No, there has never been a stock split.
Vector Science and Therapeutics Corp Profile
| - Industry | - Sector | Mr. William Jackson CEO | TSX-V Exchange | - ISIN |
| CA Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Vector Science and Therapeutics Corp. is an innovative company that specializes in the development and sale of advanced biomechanical devices alongside active localized drug-delivery platforms. With a focus on enhancing site-directed interventions, the company employs its proprietary Smart, Steered, and Sustained framework to facilitate effective musculoskeletal tissue regeneration. Headquartered in Mequon, Wisconsin, Vector Science and Therapeutics Corp. is poised to make a significant impact in the field of regenerative medicine. The company has partnered with MPP Group LLC under a development and manufacturing agreement to create pharmaceutical-grade peptides and related drug delivery devices, ensuring that its products meet the highest standards of quality and effectiveness.
Products and Services
- Biomechanical Devices: These state-of-the-art devices are designed to interact with musculoskeletal tissues for optimal regeneration. They incorporate advanced technology to facilitate healing and recovery through mechanical stimulation, targeting specific areas of the body to enhance tissue repair processes.
- Active Localized Drug-Delivery Platforms: Featuring cutting-edge delivery mechanisms, these platforms enable precise release of therapeutic agents directly to the affected tissues. This targeted approach minimizes side effects and maximizes treatment efficacy, making it ideal for patients undergoing recovery from injuries or surgical procedures.
- Smart, Steered, and Sustained Framework: This unique framework underpins the development of the company’s interventions, allowing for a tailored approach to musculoskeletal regeneration. The framework emphasizes intelligent control over the delivery of therapeutic agents, ensuring they are released in alignment with the body's healing processes.
- Pharmaceutical-grade Peptides: Under its agreement with MPP Group LLC, the company is involved in the development of high-quality peptides that serve as critical components in various treatments. These pharmaceutical-grade peptides are manufactured to stringent standards, ensuring purity and effectiveness for therapeutic applications.
- Custom Drug Delivery Devices: Vector Science and Therapeutics offers bespoke solutions for drug delivery tailored to specific patient needs. These devices are designed to accommodate various therapeutic protocols, enhancing the overall treatment experience and outcomes for patients.
Contact Information
Address: 12250 Corporate Parkway, Mequon, WI, United States, 53092
Phone: (833) 832-8724
Website: https://vectorscience.co
